In a document revealed today by Le Figaro, doctors from Urcam (Regional Union of Health Insurance Funds) were already alarmed in 1998 at the cost of refund of Pick for Social Security.
Indeed, this document sent to the Medicines Agency, estimated at 4 million francs per year the cost of reimbursing the Mediator for Burgundy. An important figure especially as it seems unjustified for the doctors of the Urcam. The report states “questions have arisen about the real medical utility of the Pick”.
Urcam doctors also raised the question of the reclassification of the drug from Servier laboratories, used as appetite suppressant “A reclassification in the amphetamine group with the related legislation (restricted prescription) appears to be the necessary first level measure. Beyond that, one can question the legitimacy of reimbursing a drug whose therapeutic indications do not are not respected and therefore do not respond to a concern for quality, safety and efficiency “.
In 1999 and again in 2006, the Medicines Transparency Commission expressed unfavorable opinions regarding the reimbursement of the Mediator which, according to them, was not sufficiently effective. However, the drug will continue to be reimbursed at 65% until 2009.
